Medium materiality6/10
Best Buy downgraded, Bristol Myers upgraded: Wall Street's top analyst calls
Why it may matterVerify against the original reporting
bullish
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
Roth Capital upgrades BMY; target $75 vs price $63.47; implies upside.
- Target $75; price $63.47; Upgrade.
Key facts
- 01
Target: $75
- 02
Posted price: $63.47
- 03
Analyst firm: Roth Capital
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.